Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
doi:10.1021/acsinfecdis.0c00288 Ghezzi P, Lemley KV, Andrus JP, De Rosa SC, Holmgren A, Jones D, Jahoor F, Kopke R, Cotgreave I, Bottiglieri T, Kaplowitz N, Nakamura H, Staal F, Ela SW, Atkuri KR, Tirouvanziam R, Heydari K, Sahaf B, Zolopa A, Frye RE, Mantovani JJ, Herzenberg LA, Herzenberg LA
We've seen this happen time and again
AbbVie announces positive topline results from a phase 1 multiple ascending dose study of ABBV-295, a long-acting amylin analog, in adults
5-Amino-1MQ research compound, also known as 5-Amino-1-Methylquinolinium
Written requests made by qualified medical or scientific professionals, addressed to the corresponding authors, for access to the full trial dataset (individual de-identified participant and perfusion data) will be considered on a case-by-case basis within 3 months of receipt
Trial and label protocols hold the current step when nausea, vomiting, constipation, reflux, or food aversion has not settled
US$ 26.22
US$ 25.71
US$ 22.78
US$ 28.68
US$ 26.63
US$ 28.56
US$ 23.50
US$ 25.75
US$ 28.37
US$ 25.80
US$ 22.13
